Axis Capital had recently initiated coverage on MCX with a “buy” rating and a price target of ₹12,500. UBS too, had raised its target to ₹12,000 from ₹10,000 earlier, having upgraded it to a “buy” rating back in October 2024.
Axis Capital had recently initiated coverage on MCX with a “buy” rating and a price target of ₹12,500. UBS too, had raised its target to ₹12,000 from ₹10,000 earlier, having upgraded it to a “buy” rating back in October 2024.